VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,153,218
- Total 13F shares
- 236,349,218
- Share change
- -4,477,837
- Total reported value
- $17,416,160,042
- Put/Call ratio
- 85%
- Price per share
- $73.67
- Number of holders
- 470
- Value change
- -$346,305,205
- Number of buys
- 204
- Number of sells
- 238
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
9.2%
|
23,483,388
|
$2,047,986,000 | — | 30 Sep 2016 | |
| FMR LLC |
13F
|
Company |
9%
|
22,937,743
|
$2,000,399,000 | — | 30 Sep 2016 | |
| Capital World Investors |
13F
|
Company |
8.8%
|
22,292,383
|
$1,944,119,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
15,602,091
|
$1,360,659,000 | — | 30 Sep 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.7%
|
14,423,839
|
$1,257,901,000 | — | 30 Sep 2016 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
11,465,587
|
$999,917,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.3%
|
11,027,089
|
$962,112,000 | — | 30 Sep 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.4%
|
8,695,431
|
$758,327,000 | — | 30 Sep 2016 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.9%
|
7,299,009
|
$636,547,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2.6%
|
6,492,221
|
$566,187,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
2.5%
|
6,262,876
|
$546,185,000 | — | 30 Sep 2016 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2%
|
5,180,761
|
$451,814,000 | — | 30 Sep 2016 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.6%
|
4,041,848
|
$352,489,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
3,594,703
|
$313,494,000 | — | 30 Sep 2016 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
3,066,951
|
$267,470,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
3,035,714
|
$264,746,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
2,972,796
|
$259,258,000 | — | 30 Sep 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
2,775,335
|
$242,036,000 | — | 30 Sep 2016 | |
| BlackRock Group LTD |
13F
|
Company |
0.94%
|
2,393,578
|
$208,744,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
2,046,369
|
$178,167,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.65%
|
1,664,342
|
$145,148,000 | — | 30 Sep 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.65%
|
1,641,196
|
$143,129,000 | — | 30 Sep 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.63%
|
1,612,000
|
$140,583,000 | — | 30 Sep 2016 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,609,897
|
$140,399,000 | — | 30 Sep 2016 | |
| NORGES BANK |
13F
|
Company |
0.66%
|
1,675,053
|
$139,524,000 | — | 30 Sep 2016 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.61%
|
1,562,258
|
$136,244,000 | — | 30 Sep 2016 | |
| BB BIOTECH AG |
13F
|
Company |
0.56%
|
1,415,445
|
$123,441,000 | — | 30 Sep 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.55%
|
1,401,709
|
$122,243,000 | — | 30 Sep 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.55%
|
1,386,119
|
$120,883,000 | — | 30 Sep 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
1,385,325
|
$120,815,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.52%
|
1,328,229
|
$115,830,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.5%
|
1,270,033
|
$110,760,000 | — | 30 Sep 2016 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.48%
|
1,231,092
|
$107,364,000 | — | 30 Sep 2016 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.47%
|
1,197,473
|
$104,429,000 | — | 30 Sep 2016 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.45%
|
1,153,973
|
$100,639,000 | — | 30 Sep 2016 | |
| Legal & General Group Plc |
13F
|
Company |
0.41%
|
1,037,635
|
$90,492,000 | — | 30 Sep 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.41%
|
1,033,503
|
$90,132,000 | — | 30 Sep 2016 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.38%
|
965,249
|
$84,179,000 | — | 30 Sep 2016 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.33%
|
839,485
|
$73,211,000 | — | 30 Sep 2016 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.3%
|
759,700
|
$66,253,000 | — | 30 Sep 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.29%
|
747,233
|
$65,167,000 | — | 30 Sep 2016 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.29%
|
734,910
|
$64,092,000 | — | 30 Sep 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.29%
|
733,751
|
$63,991,000 | — | 30 Sep 2016 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.29%
|
732,603
|
$63,890,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
725,821
|
$63,300,000 | — | 30 Sep 2016 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
685,009
|
$59,740,000 | — | 30 Sep 2016 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.27%
|
684,721
|
$59,715,000 | — | 30 Sep 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
669,086
|
$58,351,000 | — | 30 Sep 2016 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.25%
|
626,485
|
$54,635,000 | — | 30 Sep 2016 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.23%
|
578,234
|
$50,428,000 | — | 30 Sep 2016 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2016
As of 31 Dec 2016,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
470 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
236,349,218 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, JPMORGAN CHASE & CO, AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, and BlackRock Fund Advisors.
This page lists
470
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
480
Q4 2016 holders
470
Holder diff
-10
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.